Skip to content
Hugin
Hugin / Topic

patient-safety

Every record this desk has filed under patient-safety, newest first, each with the number of sources it can still show you.

6 recordsSeptember 27, 2026 – November 10, 2026All topics
  1. News1 receipt2 min

    FDA approves Sunharbo to reduce stroke risk in a defined group of adults after stroke or high-risk TIA

    FDA approved Sunharbo on November 9 for use with antiplatelet therapy after certain recent strokes or high-risk transient ischemic attacks. The agency reports a 26% lower ischemic-stroke risk than placebo in the study, alongside bleeding cautions. The drug is not approved to prevent stroke in patients with atrial fibrillation, and the reported reduction is relative rather than a percentage-point change.

    Also filed underhealthdrug-approvalsstrokefood-and-drug-administration

  2. News1 receipt2 min

    FDA approves hepatitis B treatment for some adults already taking antiviral medicine

    FDA approved Hibsago on October 20 for certain adults with chronic hepatitis B who do not have cirrhosis and meet treatment and laboratory requirements. Across two trials, 24% of treated patients qualified to stop their existing medicine. The injection carries a boxed warning for serious liver reactions and low platelet counts.

    Also filed underhealthhepatitis-bdrug-approvalsfda

  3. News1 receipt2 min

    FDA approves first generic once-weekly hormone patch for women with an intact uterus

    FDA's October 20 announcement says the agency approved the first generic Climara Pro patch the previous day. The once-weekly estrogen and progestogen patch is approved for specified menopause symptoms and osteoporosis prevention in women with an intact uterus. FDA identifies the manufacturer but gives no selling price or availability date.

    Also filed underhealthmenopausegeneric-drugsdrug-approvals

  4. News3 receipts3 min

    A cable inside React Health's VOCSN ventilators, machines used in homes as well as hospitals, can work loose after a hard knock such as a drop and make the machine reboot; the FDA's September 23 early alert covers every unit with serial number 112786 or higher, and the company's September 17 letter says to keep backup ventilation ready and run a checkout procedure after any drop.

    The Food and Drug Administration issued an early alert on September 23 for React Health's VOCSN ventilators, which are used at home as well as in hospitals and in transport, for patients from children to adults weighing at least 5 kg. A cable inside the machine can come partly or fully unseated, and a hard knock such as a drop can cause it; the ventilator can then reboot and show recurring System Fault 10 alarms. A reboot during use would interrupt ventilation. The alert covers every VOCSN-series machine with serial number 112786 or higher. React Health's September 17 letter to customers says to keep backup ventilation working and ready, keep the machine on a flat, stable surface or in its roll stand or carry bag, run the manual's Checkout Procedure after any drop or impact, and not stop therapy without an alternative and a clinician's instruction. The company says no reboots during therapy have been reported and calls that risk remote; as of August 12, 2026, it had reported no serious injuries or deaths. Questions go to React Health at 844-698-6276.

    Also filed underfdamedical-devicesventilatorshome-carecaregivers

  5. News7 receipts4 min

    The FDA has put Abiomed's removal of every Automated Impella Controller, the console that runs the Impella heart pump, in its most serious recall class; Abiomed has reported 37 serious injuries and three deaths associated with a failing sensor part, and hospitals may keep using the controllers until that part is replaced.

    On September 24 the Food and Drug Administration said it had classified Abiomed's removal of its Automated Impella Controllers, the consoles that run the Impella heart pump, as a Class I recall, the most serious type. A part in the controller's purge pressure sensor assembly, the purge flag, can fail, so the controller stops recognizing the purge disc and raises a 'Purge Disc Disconnected' or 'Purge Disc not Detected' alarm. Clearing it can mean swapping the controller, which can delay the start of support or briefly interrupt it. As of August 17, Abiomed had reported 37 serious injuries and three deaths associated with the issue. Every controller worldwide is in scope, and FDA's three recall database entries together list 10,754 units, 7,005 of them in the United States. Hospitals may keep using them until Abiomed services them, and are told to switch to a backup controller if the alarm will not clear. Abiomed began the recall with letters on August 12. A separate FDA early alert, current as of September 23, lists 237 controller serial numbers needing hardware, firmware or software updates; no serious injuries or deaths were reported for that issue as of September 8.

    Also filed underfdamedical-devicesdevice-recallsheart-pumpabiomedhospitals

  6. News6 receipts4 min

    A customer found a bag of concentrated potassium chloride inside a wrap labeled as saline, and Otsuka ICU Medical has recalled saline lot 1042188, distributed in the United States from December 30, 2025 to June 22, 2026; it is the third recall this desk found since February 2025 in which an ICU Medical-brand potassium chloride bag sat in a wrap that did not match it.

    Otsuka ICU Medical LLC is recalling one lot of 0.9% Sodium Chloride Injection, USP, 100 mL (NDC 0990-7984-23, lot 1042188, expiring 31 October 2027) after a customer found a bag of highly concentrated 10 mEq potassium chloride injection (NDC 0990-7074-26, lot 1035181) inside the saline's overwrap. The lot was manufactured November 13, 2025 and distributed in the United States from December 30, 2025 through June 22, 2026. The company's announcement, dated September 17 and posted by FDA on September 21, says inadvertent injection of concentrated potassium chloride can cause harm up to death from cardiac arrest, and that the company has received no reports of adverse events. Customers, including distributors, are asked to check their inventory, quarantine the lot and stop using it. This desk found two earlier recalls, in February and October 2025, in which ICU Medical-brand potassium chloride bags sat in wraps that did not match them; FDA classified both Class I, its most serious category. FDA's enforcement data, last updated September 16, held no classification for the new recall when this desk looked.

    Also filed underfdadrug-recallhospitalsiv-fluidsmedication-errors

A record appears here because it carries patient-safety in its own tags. If a record you expected is missing, it was filed under a different subject — the full list is on the topics index.